Furthermore, subsequent whole-exome sequencing (WES) of CLL and germline DNA samples revealed that SAMHD1 was recurrently mutated in 2.5% (4/160) of CLL patients [44]. The gene discussed is SAMHD1; the disease is B-cell chronic lymphocytic leukemia.